Ausgabe 5/2017
Inhalt (13 Artikel)
PD-1 and PD-L1 antibodies in cancer: current status and future directions
Arjun Vasant Balar, Jeffrey S. Weber
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls
Steffen Goebel, Astrid Kehlen, Karen Bluemke, Wolfgang Altermann, Gerald Schlaf, Kersten Fischer, Paolo Fornara, Bernd Wullich, Sven Wach, Helge Taubert
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy
Laura Lattanzio, Nerina Denaro, Daniela Vivenza, Chiara Varamo, Giuliana Strola, Mirella Fortunato, Emmanuel Chamorey, Alberto Comino, Martino Monteverde, Cristiana Lo Nigro, Gerard Milano, Marco Merlano
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
Viktoria Bergqvist, Erik Hertervig, Peter Gedeon, Marija Kopljar, Håkan Griph, Sara Kinhult, Ana Carneiro, Jan Marsal
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1
Anchana Rathinasamy, Christoph Domschke, Yingzi Ge, Hans-Henning Böhm, Steffen Dettling, David Jansen, Felix Lasitschka, Ludmila Umansky, Markus H. Gräler, Jennifer Hartmann, Christel Herold-Mende, Florian Schuetz, Philipp Beckhove
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress
Kousaku Mimura, Ley-Fang Kua, Noriko Shimasaki, Kensuke Shiraishi, Shotaro Nakajima, Lim Kee Siang, Asim Shabbir, Jimmy So, Wei-Peng Yong, Koji Kono
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice
Matthew G. Thompson, Daniel S. Peiffer, Michelle Larson, Flor Navarro, Stephanie K. Watkins
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
Lei Wu, Wei-Wei Deng, Cong-Fa Huang, Lin-Lin Bu, Guang-Tao Yu, Liang Mao, Wen-Feng Zhang, Bing Liu, Zhi-Jun Sun
Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells
Vinodh Kannappan, Kate Butcher, Malgorzata Trela, Iain Nicholl, Weiguang Wang, Kesley Attridge
Intralesional treatment of metastatic melanoma: a review of therapeutic options
Benjamin Weide, Dario Neri, Giuliano Elia
Evolution of MHC-based technologies used for detection of antigen-responsive T cells
Amalie Kai Bentzen, Sine Reker Hadrup
Exercise and cancer: from “healthy” to “therapeutic”?
Manja Idorn, Per thor Straten
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10–12, 2016
Judith Theelen, Jennifer Braun, Helen Hörzer, Bjoern-Philipp Kloke, Martina Ott, Irene Pizzitola, Uwe Schirmer, Matthias Miller